Genetherapy

Archive for the ‘Anti-Aging Medicine’ Category

Lumixyl™ Brightening System

A New Physician-Grade System Designed to Safely Address the Signs of Hyperpigmentation

New York, NY—Envy Medical, Inc., introduces the new Lumixyl™ Brightening System, a revolutionary multi-faceted approach to effectively treat hyperpigmentation without irritation or other side effects associated with prescription Hydroquinone or retinoids. This professional skincare system introduction builds on the success of the Lumixyl Topical Brightening Crème introduced in 2009.

“The Lumixyl Topical Brightening System is an entirely new approach to naturally brighter, more vibrant skin, representing a new physician-grade standard in skincare,” explains Dr. Basil Hantash, MD, PhD, a board certified Stanford-trained dermatologist and vice-chairman of the board at Envy Medical, who also helped develop the Lumixyl peptide technology.

Dr. Hantash

An innovation in skin brightening technology, the four products in the Lumixyl Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence. For most patients these formulations can eliminate the need to use hydroquinone or its bi-products, which are controversial due to their potential side effects. Lumixyl products are proven to be powerful but gentle on skin.

“Physicians and the public at large have been calling for a viable alternative to prescription hydroquinone therapies,” commented Envy Medical CEO, Curtis A. Cluff. “We are very pleased to be able to answer that call with a system that provides visible brightening with a safe and non-irritating formula.”

The Lumixyl Topical Brightening System builds on the four products including Active-Prep Cleanser, the Topical Brightening Creme, GlycoPeel 20 Rapid Exfoliating Lotion, and Moisture-Lock Sunscreen SPF 30. The products are ideal for all skin types. Lumixyl Brightening System retails for $270 for four full size products.

Developed by Envy Medical, Inc. and dermatological researchers at Stanford University, Lumixyl products are made exclusively for dermatologists, plastic surgeons and skin oriented aesthetic physicians. The products are manufactured and sold by Envy Medical in the United States and distributed internationally by Toronto Canada-based Basis Medical Technologies.

About BASIS
BASIS Medical Technologies specializes in the development and distribution of groundbreaking technologies in medicine and medical aesthetics. Headquartered in Toronto, Canada, BASIS is an innovative technology platform with sales, marketing and training capabilities around the world. With an experienced management team and medical advisory panel, BASIS is committed to delivering and developing cutting-edge medical products internationally. Basis is an exclusive market representative for Lumixyl in markets throughout the world, a product licensed by Envy Medical Inc.

About Envy Medical
Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company’s lead products include SilkPeel®, a breakthrough device combining exfoliation with dermalinfusion® for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available as a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage.

Envy Medical
888.848.3633
www.envymedical.com

Source: Envy Medical

Aesthetic Trends & Technologies
March | April 2010
Wellness Department

By Paula Simpson, B.A.Sc. (Nutrition), R.N.C.P., Contributing Editor & Advisor

The aging process is one of the best examples of the effects of deteriorating homeostasis. Aging is accompanied by an impairment of the physiological systems including the homeostatic systems such as the immune system. The free radical theory of aging (one of the most widely accepted theories) proposes to explain aging according to which oxygen-derived free radicals cause age-related impairment through oxidative damage to biomolecules, with mitochondria being the main target of free radical attack. Since oxygen radicals are needed for many metabolic and physiological processes, a balance between radical production and their antioxidant-linked inactivation is required to preserve health.

The skin, being the largest organ in the body and barrier from the external environment, is very susceptible to damage produced by free radicals due to its constant contact with oxygen and other environmental stressors, such as UV exposure. This damage caused by free radicals impairs the ability of the cells to transport nutrients, eliminate wastes, and reproduce healthy skin cells, in turn causing an
accumulation of chemical events and by products that deteriorate and interfere with the normal functions of the skin. Over time, inflammation and the degradation of collagen and elastin reveal the signs of physical aging of the skin.

Chronic sun exposure, smoking, poor dietary intake, and lifestyle have been well documented as key accelerators in skin aging due to an imbalanced homeostasis. Clinical studies show that age-dependent changes of the immune system are linked to oxidative stress and that an adequate intake of dietary antioxidants may protect those systems (including skin) against…READ ON – Click Here to Download Article

About Ms. Simpson
Paula Simpson, B.A.Sc. (Nutrition), R.N.C.P. is the Executive Director of Isocell North America and holds a degree in Nutrition. She has over 15 years of experience in consulting, public relations, product formulation, and program development for the Nutraceutical and Medical Aesthetic Industry. Her role as a Scientific Evaluator and Regulatory Consultant for some of the top nutraceutical companies worldwide has solidified her reputation as a leader in research and development for innovative natural health products. As a Project Leader, Paula developed and guided an international weight loss program towards a successful launch in North America and Europe. As the Nutrition Director for a medical spa, she developed a weight management and longevity program that was the impetus for the company’s overall commercial success. Ms. Simpson can be contacted directly at paula.simpson@glisodinskin.com. Visit their website on the worldwide web: www.glisodinskin.com.

Aesthetic Trends & Technologies
March | April 2010 Issue
Practice Management Department

By Wendy Lewis, Contributing Editor & Advisor

If you wonder why some medical practices and certain doctors seem to receive all the media coverage, the reason is that they have someone behind the scenes making it happen. Ultimately, the goal of a public relations campaign is to generate exposure for your practice or medspa and your brand by employing a variety of media vehicles to reach your targeted consumer. A well orchestrated public relations program allows you to create long-term relationships with key media that may include editors, writers, producers, researchers, reporters, anchors, presenters, bloggers, and their assistants, associates, and colleagues.

Placements generated may include television segments, radio programs, local newspapers, national publications, monthly magazines, newsletters, websites, ezines, and blogs. PR is a key component of your brand strategy because it is a vehicle that can be driven but not fully controlled by you. Thus, a third-party endorsement reinforces and authenticates the message of your expertise to prospective patients and customers in a way…READ ON – Click Here to Download Article

About Ms. Lewis
Wendy Lewis is the President of Wendy Lewis & Co., Ltd., global aesthetics consultancy established in 1997 and an internationally renowned expert in social media strategy and practice marketing. She is the author of 10 books on aesthetics and beauty and Founder and Editor in Chief of www.beautyinthebag.com. Contact her at 1.877.WLBEAUTY; wl@wlbeauty.com. Visit her on the worldwide web: www.cosmeticmedrx.com.

Aesthetic Trends & Technologies
March | April 2010
Plastic Surgery Department

By Joseph A. Eviatar, M.D., F.A.C.S.

The U.S. Food and Drug Administration (FDA) has recently approved Dysport™, a “next generation” acetylcholine release inhibitor and neuromuscular blocking agent indicated for the temporary improvement of the appearance of moderate to severe glabellar or frown lines between the brows. Dysport, marketed by Medicis Aesthetics, the distributers of Restylane and Perlane, has been used in over two million treatments worldwide in 27 countries.

STAYING POWER OF DYSPORT
In the seven years since its FDA clearance, BOTOX® Cosmetic has taken the aesthetic world by storm. Yet, the chief complaint among BOTOX® patients is its staying power. Many come to experience injection fatigue where the duration between treatments becomes shorter and shorter. This is where Dysport may outshine BOTOX®.

Clinical studies and patient reports have shown that Dysport may last up to six months compared to the four to five months that BOTOX® is effective. Research also shows Dysport takes effect more quickly, usually within 48 hours. In addition to frown lines, Dysport is used (off label) around the eyes (crow’s feet), for brow lifting, and on the forehead to reduce dynamic lines and wrinkles. It can also be used to treat prominent neck bands or cords. Although great results are…READ ON – Click Here to Download Article

About Dr. Eviatar
Joseph A. Eviatar, M.D., F.A.C.S., is an Assistant Clinical Professor of Ophthalmology at New York Medical College, an Attending Surgeon at New York Eye & Ear Infirmary and Director of Oculoplastics at SUNY School of Optometry. He performs medical research, lectures to his colleagues, and is often featured in the press. He is a recognized expert in multiple cosmetic non-invasive treatments and has performed thousands of surgical and laser procedures for aesthetic facial rejuvenation and reconstruction. For more information on this topic, please contact Dr. Eviatar at: 212.272.3717or visit his website at: www.chelseaeye.com.

Aesthetic Trends & Technologies
March | April 2010
Plastic Surgery Department

By Todd K. Malan, M.D.

Recent technological advances have allowed me to pioneer a procedure, the Stem Cell Enhanced Natural Breast Augmentation, which incorporates the latest advances in fat harvesting, adult stem cell transfers, and breast splinting technology to provide women the option of enlarging their breasts using their own fat, eliminating the need of unnatural implants.

HISTORICAL DATA
Since the late 1980s, autologous fat transfer for breast augmentation and reconstruction has remained a highly controversial procedure following its introduction in the U.S. Concerns regarding poor graft, survival, calcifications, liponecrotic cysts, and obscuring mammography had relegated this procedure to little more than a historical footnote. Modern advances in fat harvesting and transfer techniques, digital mammography, and the use of adipose derived adult stem cells and regenerative cells demand a reexamination of this long-standing bias against fat transfer breast augmentation.

Free fat for body contour correction has been widely accepted and is considered an excellent technique throughout the cosmetic industry. Since fat has a higher viscosity than normal saline and shares a similar texture and feel as normal breast tissue, it seems logical to replace…READ ON – Click Here to Download Article

About Dr. Malan
Todd K. Malan, M.D.. founded the Innovative Cosmetic Surgery Center in Scottsdale AZ to help improve advanced research and physician training in minimally invasive cosmetic surgery techniques and to provide patients with safe and reliable options to traditional surgery.

Dr. Malan continuously expands his knowledge and training to maintain industry leadership, which constantly places him at the forefront of advancements. He is a nationally recognized speaker and educator on the Natural Breast Augmentation and advanced body contouring procedures. His expertise is evident through his respected surgery center, technological developments, loyal patient following, and peer recognition. For more information about this topic, please visit Dr. Malan on the worldwide web: www.smartliposurgery.com, or call: 866.985.7999.

Aesthetic Trends & Technologies
March | April 2010
Organics & Green Department

By Emily Stocker, Contributing Editor & Advisor

Think of beauty products the same way you do the food that you put in your body. Top chefs in elegant restaurants use high-quality ingredients, fresh herbs, and real spices. They do not use artificial flavors or synthetic ingredients simply because it would compromise the integrity of their food.

The recent increase in public awareness of the actual ingredients contained within the food we eat has led mindful consumers to become “label readers” in an effort to control what they put into their bodies. The international organic food production has grown at a rate of around 20 percent a year since the early 1990s. Naturally, the trends of organic beauty products have begun to run parallel with those of the organic food industry, growing by 15 percent annually over the past fifteen years. However, such extensive growth of the industry has placed “organic” labeled products under the scrutiny of watchful consumers.

Nowhere does the label “organic” take a more gratuitous bruising than in the beauty products industry. There are clear guidelines for organic food because organic industry standards were designed specifically for food production. When you see the word organic on a beauty product, it may not mean exactly what you presume it to mean. Minimal regulation has allowed for grossly inadequate labeling.

European-based organizations have begun attempts at creating an international industry standard, requiring high levels of organic ingredients – anywhere from 85-95 percent. Although these standards give consumers the impression that little or no chemical ingredients are in the product, they have received harsh criticism from the Organic Consumers Association for…READ ON – Click Here to Download Article

About Ms. Stocker
Emily Stocker steps into the business of being green (and happy) with Em’s Organics, offering products like sea sponge soap made from USDA Organic ingredients and baby and children’s clothing and accessories. And that’s just the beginning. Why buy
organic products? Because they’re better. Visit her website: www.EmsOrganics.com, which will officially launch on April 22nd, Earth Day.

Aesthetic Trends & Technologies
March | April 2010 Issue
Laser & Light Technology Department

By Jeffrey C. Caruth, M.D.

Body contouring to eliminate love handles and other “problem” areas on the abdomen, thighs, under the bra line, and on the hips is one of the most popular cosmetic procedures in the U.S. today. As we all know, even with proper diet and exercise many men and women find it nearly impossible to get rid of bulges and unsightly pockets of fat to achieve the body image they desire.

Liposuction, the traditional method of fat removal, has been effective; but there are often unintended side-effects, including potential damage to connective tissues, the risk of fluid build-up, and a rippling or distortion of the tissues, leading to patient dissatisfaction and requests for a second “touch-up” corrective procedure.

More recent advances, such as the ultrasonic liposuction and laser assisted liposuction, represent an improvement in the technology; but these techniques also continue to have certain drawbacks and inherent risks, including damage to the skin from burns. Now an alternative body contouring innovation has been introduced that takes patient safety, comfort, and satisfaction to the next level.

Cleared by the FDA in summer 2008, the Body-Jet Water-Assisted Liposuction (WAL) offers many advantages both for the physician and the patient. From my experience, the technique is not only an easy one to learn, but it achieves superior results with high patient satisfaction. There is a shorter operating time and a faster recovery period. Patients experience less bruising and reduced pain. Usually, only local anesthesia is needed so the patient is awake…READ ON – Click Here to Download Article

About Dr. Caruth
Jeffrey C. Caruth, M.D., is a Board Certified Gynecologist who is at the leading edge of the many advanced cosmetic surgical techniques. He offers patients the latest advances in body contouring, breast augmentation, and facial rejuvenation and is certified in many of these pioneering innovations, including the new Body-Jet Water-Assisted Liposuction, Fractional CO2 Skin Resurfacing, Advanced BOTOX®, Advanced Filler Injections, Vaser LipoSelection, and SmartLipo Body Contouring. For more information regarding this topic, visit Dr. Caruth’s website: www.planoaesthetics.com.

Aesthetic Trends & Technologies
March | April 2010 Issue
Laser & Light Technology Department

By Jasmina Kozarev, M.D.,
Specialist in Dermatovenerology

The demand for tattoo removal treatments is undeniably growing. Up to 20 million people in the United States have at least one tattoo, and a recent survey suggests that 17% of people sporting a tattoo consider having it removed. The reasons for wanting to remove tattoos are plentiful and so is the multitude of treatments available to patients. Lasers have certainly made their mark in this area in recent years; and there is a plethora of systems out there emphasizing various technical specifications and features, and most importantly carrying different price tags.

Technological developments have not only furthered the treatment of tattoos but have also made the most advanced tattoo removal lasers extremely versatile and applicable in the treatment of various pigmented skin conditions and treatments in Asian skin types. How does laser tattoo removal work? And, as a practitioner looking into expanding your practice’s treatment range, what kind of specifications and features should you look for? We aim to give you some guidance based on concrete practical experience…READ ON – Click Here to Download Article

About Dr. Kozarev
Jasmina Kozarev, M.D., is a graduate of Novi Sad’s Faculty for Medicine and has over 15 years of clinical experience as a specialist in dermatovenerology. She is the founder of the Dr. Kozarev Dermatology Laser Clinic, Serbia, where she practices dermatology and aesthetic laser medicine. She was the first to perform CO2 laser surgery in Serbia and has accumulated a wealth of clinical and academic experience in laser treatments throughout her career.

Given her long-term experience with a tremendous variety of laser sources, Dr. Kozarev is a true expert in the field of Aesthetic Laser Medicine. She contributes to the field both from a practical, clinical point of view, as well as research and development of applications. For more information on the QX MAX, visit the Fotona website: www.fotona.com or call: 888.550.4113.

Aesthetic Trends & Technologies
March | April 2010 Issue
In Practice Department

Practice Philosophy – The Three “A”s

When Dr. Alexander Gross launched his primary dermatology practice almost 20 years ago, he did so with a basic philosophy for success. He adopted a mindset of The Three “A”s: Ability, Affability, and Availability. These core sensibilities are what Dr. Gross believes have set the ground work for sustaining his large and ever-evolving surgical and cosmetic dermatology practice.

• Ability – Having the necessary training and skills to deliver on patient expectations and

• Affability – Making yourself and your team open to establishing a relationship with patients on a personal level – “bedside manner”

• Availability – Being obtainable and reliable as pertains to your patients’ needs for attention and service

ABILITY
When it comes to ability, Dr. Gross practices what he preaches. He received a Bachelor of Science degree from Emory University and then attended medical school at the University of South Florida. He completed an internship and residency in internal medicine at Emory University and a dermatology residency and fellowship at Vanderbilt University. Dr. Gross is board certified in both internal medicine and dermatology.

In addition to his full-time practice at the Georgia Dermatology Center, Dr. Gross is an attending physician at Northside Forsyth Hospital. He volunteers his services to the community, and he also trains other physicians to perform tumescent liposuction and soft tissue filler injections. He is an Assistant Clinical Professor of Dermatology at Emory, a preceptor for…READ ON – Click Here to Download Article

About Dr. Gross
Dr. Gross’s extensive involvement and experience in the field of medicine has led him to many awards and honors. He was named the winner of the Dermatology Abstract Symposium at Vanderbilt University in June of 1990. Because of his dedication and work with The American Cancer Society, Dr. Gross was named Cancer Control Volunteer of the Year in 2008. He recently won the President’s Volunteerism Award, and will serve on the Georgia Composite Medical Board, becoming Chairman July 1st of this year.

Dr. Gross continues to give back to the community with his time and is always available to speak with other medical professionals. To learn more about Dr. Alex Gross and his practice, please visit his website at www.gadermctr.com or contact him directly at axel144@aol.com.

Aesthetic Trends & Technologies
March | April 2010 Issue
Dermatology Department

By Neil S. Sadick, M.D., FAAD, FAACS, FACP, FACPh
Contributing Editor & Advisor

Artefill® was the first nonresorbable soft tissue filler to be cleared by the U.S. Food and Drug Administration. This advanced polymethylmethacrylate (PMMA) microsphere containing dermal filler was cleared by the FDA in October 2006 and is the only permanent filler currently available in the U.S. market today. To date, more than 20,000 patients have been treated with Artefill.

It is well established that PMMA microsphere surface characteristics, purity, and microsphere size are critical factors that influence product safety. Although microsphere quality in PMMA containing products available around the world has improved in recent years, healthcare providers may have misconceptions regarding the safety of newer PMMA fillers, such as Artefill. The previous owners of Artefill along with its current owner and manufacturer (Suneva Medical, San Diego, CA) have invested significant resources to improve the physical/chemical properties, formulation, and processing of Artefill to distinguish it…READ ON – Click Here to Download Article

About Dr. Sadick
Neil Sadick, MD, FAAD, FAACS, FACP, FACPh, is one of the most renowned dermatologists and researchers, and his multiple discoveries have strongly influenced and transformed the future of dermatology. Dr. Sadick’s prestigious list of titles range from Clinical Professor of Dermatology at Weill Cornell Medical College, to President of the Cosmetic Surgery Foundation, Member of the Board of Examiners for the International Society of Hair Restoration Surgery, to Global Medical Advisor for Christian Dior Beauty, to name a few.

He holds four board certifications: Dermatology, Cosmetic Surgery, Internal Medicine, and Hair Transplantation. Dr. Sadick is author, or co-author, of close to 300 articles in peer-reviewed scientific journals and has contributed more than 75 chapters of medical books. In addition, he has written or edited more than 10 books on cosmetic surgery, hair, and vein treatment. Dr. Sadick has also been a guest lecturer at more than 500 medical seminar classes and workshops worldwide. For more information regarding this topic, contact Dr. Sadick at: 212.772.7242 or visit his website: www.sadickdermatology.com.

Aesthetic Trends & Technologies
March | April 2010
Dermatology Department

By Christian Oresajo, Ph.D., Asst. V.P., R&D, L’Oréal USA

Topical application of antioxidants can complement sunscreen to protect the skin from UV damage. Combining natural based antioxidant substances with sunscreen filters can improve protection against UV rays. UV-irradiation is a potent generator of oxidative stress in the skin leading to acute inflammatory reactions, such as erythema, and chronic reactions, such as premature skin aging. Exposure of mammalian skin to UV radiation increases levels of reactive oxygen species, which damages lipids, proteins, and nucleic acids in both epidermis and dermis and contributes to the sunburn reaction as well as photo-aging.

Use of sunscreens for skin photo protection by preventing the penetration of harmful UV rays into skin is well established. However, sunscreens do not provide 100% protection against UV radiation due to various reasons including uneven application, wash-off from body surface, and insufficient protection of UV range. Several recent studies have evaluated the protective role of antioxidants from within the skin…READ ON – CLICK HERE TO DOWNLOAD ARTICLE

About Dr. Oresajo
Christian Oresajo, Ph.D., is currently Assistant Vice President, Research and Development, L’Oréal USA. Prior to joining L’Oréal, Christian worked for over 20 years performing clinical evaluations for top international companies in the personal care industry. He is a member of several professional organizations including the Society of Investigative Dermatology and the American Academy of Dermatology. Christian is coauthor of several publications and book chapters on skin-related topics, including ethnic skin, and is currently an adjunct assistant professor at Howard University School of Medicine, Department of Dermatology, Washington, D.C. He holds a Ph.D. degree in Biochemistry from American University, Washington, D.C. For more information on this topic, visit the La Roche-Posay L’Oréal USA website at: www.anthelios.com, or contact La Roche-Posay directly at: 800.560.1803.

Aesthetic Trends & Technologies
March | April 2010 Issue
Dermatology Department

Preservative-Free Lidocaine Enhanced
Injectable Filler for Added Patient Comfort

By Isaac Starker, M.D.

Juvéderm® XC is a cross-linked hyaluronic acid injectable filler which was cleared for use by the FDA in January 2010. It is distributed by Allergan (Irvine, CA) and has the same FDA cleared indications for use as their Juvéderm Ultra and Ultra Plus products which were introduced in the U.S. in June 2006, namely as an injectable dermal filler at the mid to deep dermis levels for correction of moderate to deep facial wrinkles and folds. An approved example of where it may be injected is the nasolabial folds, the so called parentheses lines. Experienced injectors have also used these products in an off-label fashion in many other facial areas including…READ ON – Click Here to Download Article

About Dr. Starker
Isaac Starker, M.D., F.A.C.S. is a talented Plastic Surgeon whose technical knowledge and artistic eye combine to achieve stunning yet natural appearing plastic surgery results in New Jersey. Dr. Starker performs the full spectrum of cosmetic and reconstructive procedures. He is trained in the latest surgical techniques and in the use of the most advanced technology, including lasers, endoscopy, ultrasound and power-assisted liposuction, and computer imaging.

His surgical philosophy is based upon the premise that successful plastic surgery is a collaboration between patient and surgeon. Dr. Starker feels that he has to take the time to listen to his patient first, and only then can he suggest and perform surgery that will meet his or her wishes. A Fellow of the American College of Surgeons, Dr. Starker earned his undergraduate and medical degrees from New York University and completed general surgery and plastic surgery residencies at St Lukes-Roosevelt, Montefiore and Albert Einstein University Hospitals. He is certified by the American Board of Plastic Surgery and is active in the medical community.

He maintains memberships in numerous professional societies, including American Society for Aesthetic Plastic Surgery, American Society of Plastic Surgeons, New Jersey Society of Plastic Surgeons, and the American Medical Association. For more
information or to contact Dr. Starker, visit the Peer Group website: www.peergroupnj.com.

Aesthetic Trends & Technologies
March | April 2010 Issue
Anti-Aging Department

Porcelain Veneers

Congenitally Missing Teeth Corrected Through an Interdisciplinary Approach

By Brian Kantor, D.D.S., Contributing Editor & Advisor

As technology advances, allowing one’s appearance to be refined, enhanced, and corrected, standards of beauty have reached new levels. This is especially true in the field of cosmetic dentistry, where the once coveted Hollywood smile is now within anyone’s grasp. Simply put, no one wants to be missing front teeth, and today no one has to anymore. While some individuals lose their teeth due to specific circumstances, others are born genetically predisposed to…READ ON – Click Here to Download Article

About Dr. Kantor
Brian Kantor, D.D.S., graduated from the University of Pennsylvania with a BA degree in Biology. He graduated from New York University College of Dentistry and continued his training with an advanced education in General and Cosmetic Dentistry, also at New York University. At the forefront of the cosmetic dentistry revolution, Dr. Kantor has built an enviable reputation for unsurpassed excellence and dedication. He is a partner of the world-renowned dental practice of Lowenberg, Lituchy & Kantor.

He performs state-of-the-art “smile makeovers” using porcelain veneers as well as bonding, bleaching, and porcelain fillings. He has been featured in Gotham Magazine and has appeared on Access Hollywood, the Today Show, and Oprah earlier this year. Dr. Kantor was also featured in W Magazine as “Best Up-and-Coming Beauty Doctors of 2005.” The dental practice of Lowenberg, Lituchy & Kantor has also recently been featured on Regis and Kelly, The View, and innumerable fashion magazines.

Dr. Kantor is an active member in numerous dental societies and organizations, including the Academy of General Dentistry, The American Academy of Cosmetic Dentistry, The International Congress of Oral Implantologists, The American Dental Association, and the Dental Society of the State of New York. To contact Dr. Kantor, call: 212.586.2890, or visit their website: www.lowenbergandlituchy.com.

Coppertone® Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of the America Academy of Dermatology

Research Reveals Broad Spectrum Sunscreens Containing Antioxidants Can Provide Measurable Skincare Benefits Beyond Sun Protection

WHITEHOUSE STATION, NJ, – Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc., the makers of COPPERTONE®, announced today at the 2010 Annual Meeting of the American Academy of Dermatology the results of studies demonstrating the efficacy of topical antioxidants in broad spectrum sunscreens.

An ex vivo study conducted by an independent researcher for the COPPERTONE® Solar Research Center revealed that using certain antioxidants in sunscreens reduced the formation of damaging free radicals by 74% in skin’s outer layers exposed to UV. This provides significant evidence that sunscreen products containing certain antioxidants can help fortify skin’s natural defenses. The implications of this research are especially pertinent to those whose skin may be more vulnerable to the effects of sun exposure due to outdoor exercise activities.

A separate independent 12-week clinical (in vivo) trial demonstrated that daily use of broad spectrum sunscreens containing specialized blends of antioxidants found in select products in the 2010 COPPERTONE® sunscreen line can provide additional skin health benefits beyond UV protection.

“Emerging research shows that Vitamin E, one of the primary antioxidants in the sunscreen we tested, is a key ingredient for preserving skin’s barrier function and for helping to maintain skin health,” said Robert Bianchini, PhD, Vice President of Research and Development at the COPPERTONE® Solar Research Center. “Since Vitamin E may be lost from the skin during environmental stress, such as outdoor exercise, using a broad spectrum sunscreen with antioxidants proven to help restore these elements is important.”

Not All Antioxidants Are Equal Under UV Light
Ex vivo studies evaluated the overall effectiveness of topical antioxidants contained in the sunscreens for reducing free radical formation caused by sun exposure. Research has shown that not all topical antioxidants are equal under UV conditions. In fact, UV radiation may cause an unexpected reaction with certain topical antioxidants—including some plant extracts—when exposed to sunlight, transforming them into damaging pro-oxidants. For that reason, the researchers tested the antioxidant ingredients used in the sunscreens, COPPERTONE SPORT® with Replenishing Antioxidants and COPPERTONE KIDS® with Protective Vitamins, to ensure they continue to function properly in conditions similar to “real-world” sunscreen use.

The 12-week clinical trial showed that the daily use of sunscreen lotions with the appropriate antioxidants can also provide significant cosmetic benefits. In participants who began the study with signs of mild to moderate photodamage, clinical evaluators saw measurable improvement in a number of parameters that contribute to the cosmetic signs of premature aging, including visible dryness, mottled skin tone, laxity, roughness, and the appearance of fine lines and wrinkles.

“Topical antioxidants are rapidly emerging as a breakthrough innovation in suncare,” added Dr. Bianchini. “The results of our research demonstrate that there are many skin health benefits and applications to adding antioxidants to a sunscreen formula—and we will continue to explore advancements in how this technology can be used with sun protection to help maintain overall skin health.”

About COPPERTONE®
COPPERTONE SPORT® and COPPERTONE KIDS® are registered trademarks of Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc.

About Schering-Plough Consumer HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc.
Today’s Merck is working to help the world be well. Schering-Plough Consumer HealthCare Products, Inc. is the over-the-counter division of Merck. Each day, millions count on one or more of our industry-leading brands that help prevent or treat various common conditions. These include household names such as CLARITIN for allergies, COPPERTONE for sun care, DR. SCHOLL’S for foot care, and many more. Merck. Be well.

Merck / Schering-Plough
908.423.1000
www.merck.com
www.coppertone.com

Proposed Rule for the Establishment of Certification Programs for Health Information Technology

A Message from Dr. David Blumenthal, National Coordinator for Health Information Technology

Today the Secretary of the Department of Health and Human Services (HHS) released a notice of proposed rulemaking (NPRM) outlining the proposed approach for establishing a certification program to test and certify electronic health records (EHRs). The HITECH Act mandates the development of a certification program which will give purchasers and users of EHR technology assurances that the technology and products have the necessary functionality and security to help meet meaningful use criteria. While we are making significant strides toward modernizing our health care system, these efforts will only succeed if providers and patients are confident that their health information systems are safe and functional.

Dr. Blumenthal

The proposed rule incorporates two phases of development for the certification program to ensure that eligible professionals and eligible hospitals are able to adopt and implement Certified EHR Technology in time to qualify for meaningful use incentive payments. The rulemaking process will take time, so this phased approach provides a bridge to detailed guidelines to support an ongoing program of testing and certification of health IT.

The first proposed program creates a temporary certification process under which the National Coordinator would authorize organizations to assume many of the responsibilities that will eventually be fulfilled under the permanent certification program. For the permanent certification program, the rule proposes transitioning much of the responsibility for testing and certification to organizations in the private sector.

Publication of the proposed rule on the Establishment of Certification Programs for Health Information Technology is an important first step in bringing structure and cohesion to the evaluation of EHRs, EHR modules, and potentially other types of health IT. The programs will help support end users of certified products, and ultimately serve the interests of each patient by ensuring that their information is securely managed and available where and when it is needed.

Your input is essential to bringing this important process to fruition. We encourage your participation in the open public comment period.

Additional information on both of these programs and how you can comment can be found through the HHS news release issued today and at the http://HealthIT.HHS.Gov website.

The vision of the HITECH Act is unfolding rapidly, and all of us at ONC look forward to continuing to work with you to achieve the meaningful use of EHRs.

David Blumenthal, M.D., M.P.P.
National Coordinator for Health Information Technology
dr.davidblumenthal@hhs.gov

Source: U.S. Department of Health & Human Services

Solta Medical Announces Definitive Agreement to Acquire Aesthera

February 23, 2010
Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical’s earnings within twelve months.

In addition, there are $10 million of stretch milestones which would be paid to Aesthera shareholders if Aesthera achieves revenue ranging from $14 to $21 million in the twelve months beginning April 1, 2010. The proposed transaction becomes increasingly accretive to Solta Medical shareholders as Aesthera achieves the higher milestone revenue and payments. Aesthera’s unaudited revenue for the twelve months ended December 31, 2009 was approximately $8.5 million. Solta Medical expects to close the transaction prior to March 31, 2010.

Aesthera’s light-based treatment systems – the Isolaz™ and Isolaz Pro ™ platforms – are based on proprietary Photopneumatic™ technology and are the only laser or light based devices with FDA marketing clearance for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. These conditions impact an estimated forty-to-fifty million individuals in the U.S. annually. Isolaz treatments have an immediate visible impact on acne 24 – 48 hour post first treatment and are painless. Facial treatments take as little as 10 minutes, require no anesthetics or numbing creams, and provide additional cosmetic benefits such as smoother appearing skin.

“We are very excited to broaden our portfolio of superior solutions for dermatologists and aesthetic physician with the addition of the Isolaz brand to Solta Medical. Treatment of acne with Isolaz offers physicians and their patients an effective alternative to the risks of oral drug treatments and their associated side effects,” said Stephen J. Fanning, Chairman of the Board, President, and CEO of Solta Medical. “In addition, physicians also turn to Isolaz acne treatments for patients who have experienced little to no benefit from topical and oral antibiotic regimens in treating acne.”

“The acquisition will leverage our current call point, and provides compelling opportunities to leverage our marketing resources targeting both physicians and consumers. We have one of the largest global sales and marketing organizations in the industry and an extensive international distribution network. Our combined distribution strength will provide us with the ability to place systems with new customers, as well as drive sales of treatment tips to a worldwide installed base of over 6,500 systems. Our goal is to extend the cross-selling success that we demonstrated during the past year with the Thermage and Fraxel brands to the Isolaz brand,” added Mr. Fanning.

“We are very excited about becoming part of Solta Medical,” said Alon Maor, President and CEO of Aesthera Corporation. “Over the past several years, our team has built Isolaz into one of the most recognized and well respected names in the medical community for difficult to treat acne, which affects millions of people. Patients unable to find successful treatments for their acne have found solutions from dermatologists using our technology. Now, we believe that under the Solta Medical umbrella, Isolaz can achieve its full market potential, both in the U.S. and abroad.”

Shattuck Hammond Partners, a division of Morgan Keegan & Company, Inc., served as exclusive financial advisor to Solta Medical and Gravitas Healthcare, LLC served as exclusive financial advisor to Aesthera Corporation in this transaction.

Solta Medical
877.782.2286
www.solta.com

Source: Solta

New Organics & Green Department in the Aesthetic Trends & Technologies Magazine

Aesthetic Trends & Technologies has added new content among the departments of the magazine: Organics & Green. Each issue Aesthetic Trends will report on trends, statistics and product information and developments related to the aesthetic market.

NEWS BYTES

USA
Total U.S. organic sales, including food and nonfood products,were $17.7 billion in 2006, up 21 percent from 2005. They are estimated to have reached $21.2 billion in 2007, and are projected to surpass $25 billion in 2008. U.S. sales of organic food and beverages are expected to increase an average of 18 percent each year from 2007 to 2010. Organic food and beverage sales in the US could very well climb past $35 billion or more in 2010.* With a continued steady growth rate, it is conceivable that the world’s agriculture will be fundamentally organic by year 2020.

*Reference: Organic Trade Association 2007 Manufacturer’s Survey

Japan
The Japanese are the largest per capita consumer of organic products in the world.

Europe
Organic spending should nearly double every five years based on research across seven European countries.

Aesthetic Trends & Technologies
800.277.1391
www.aesthetictrends.com

Source: ATnT

ATnTechnologies Webinar Series Presents…

PRACTICE MANAGEMENT
The Power of PR: Working with the Media to Grow Your Practice

Thursday, March 18, 2010 4pm Pacific / 7pm Eastern
REGISTER – Click Here

Presenter:
Wendy Lewis

If you wonder why some medical practices and certain doctors seem to receive all the media coverage, the reason is that they have someone behind the scenes making it happen. Ultimately, the goal of a public relations campaign is to generate exposure for your practice or medspa and your brand by employing a variety of media vehicles to reach your targeted consumer.

A well orchestrated public relations program allows you to create long-term relationships with key media that may include editors, writers, producers, researchers, reporters, anchors, presenters, bloggers, and their assistants, associates and colleagues. Find out how to work with the media to grow your practice and avoid the pitfalls of performing your own PR.

Aesthetic Trends & Technologies, Inc.
800.277.1391
www.AestheticTrends.com

Source: Aesthetic Trends (ATnT)

Topical Botulinum Gel in the Works

A novel topical gel formulation of botulinum toxin type A now in the developmental pipeline may expand the range of skin problems dermatologists can tackle with the neurotoxin.

“This is intriguing on a number of levels. I think topical therapy really could be a very good thing,” Dr. Mark G. Rubin observed at the seminar.

The topical gel, being developed by Revance Pharmaceuticals, combines botulinum toxin type A with a proprietary carrier peptide that can transport the neurotoxin across the skin all the way down to the musculature.

“Without an injection we can give people results that are similar to what we see with Botox [onabotulinumtoxinA] or Dysport [abobotulinumtoxinA],” according to Dr. Rubin of the Lasky Skin Center in Beverly Hills, Calif., and the University of California, San Diego.

Mark G. Rubin, M.D.

If the topical gel—now in early clinical trials—were eventually to win marketing approval, how might it fit into clinical practice? Certainly some patients dislike needles so much that they would prefer to sit in a physician’s office with a gel on their skin for 20-30 minutes rather than get a 3-second injection and be on their way, but Dr. Rubin is unsure how many people fit that description.

There are, however, certain clinical situations where a topical preparation would offer unequivocal advantages—hyperhidrosis, for example. “Think how nice it would be to just rub a gel on instead of injecting somebody 25 times in the axilla,” he said.

A topical gel would also make it easier to use the neurotoxin to treat wrinkles at difficult-to-inject sites, such as the lower eyelids.

But perhaps the most interesting potential application for a topical botulinum toxin gel is in improving the quality of the skin. Physicians who inject botulinum toxin type A have described associated reductions in skin oiliness, pore size, and facial flushing problems. Mini-doses of a topical preparation might achieve similar improvements in skin quality without the muscle weakness induced by injecting neurotoxin, the dermatologist speculated.

A 77-patient, placebo-controlled, dose-ranging clinical trial of topical botulinum gel for the treatment of crow’s feet was presented last year. Participants received 1.65 ng of the neurotoxin combined with various doses of the carrier protein. Among those subjects whose neurotoxin was combined with at least 6 mcg of carrier there was an average 2-point improvement in lateral canthal lines on a 4-point scale.

“The results were fairly profound—certainly comparable to what you see with injectable Botox or Dysport,” Dr. Rubin commented.

Last year in the United States 2.8 million injections of neurotoxins were performed, and more than 20,000 physicians injected Botox. Sales of injectable neurotoxins are forecast to increase by more than 15% annually, according to the dermatologist.

Dr. Rubin disclosed that he serves as a consultant to Revance and Medicis. SDEF and this news organization are owned by Elsevier.

Source: Global Medical News Network

CoolTouch Acknowledges Infringement and Validity of Cynosure’s Key Laser Lipolysis Patent

Cynosure to Receive Royalties on Past and Future Sales of Lipolysis Products

WESTFORD, Mass., /PRNewswire via COMTEX/ — Cynosure, Inc. (Nasdaq: CYNO), developer of the award-winning Smartlipo(TM) LaserBodySculpting(SM) procedure for minimally invasive removal of fat, and its largest shareholder, El.En. S.p.A, today announced a settlement of their patent infringement lawsuit against CoolTouch, Inc. Cynosure and El.En. alleged that CoolTouch’s 1320 nm CoolLipo(TM) laser system infringed on El.En.’s U.S. Patent No. 6,206,873 (the 873 patent) licensed to Cynosure, which covers laser technology to remove subcutaneous fat.

Under the terms of the settlement, CoolTouch will make payments representing a 9% royalty on sales of CoolLipo made prior to the agreement and a portion of Cynosure’s legal expenses. CoolTouch also has agreed to pay a royalty rate of 10% of future net sales for any licensed product sold strictly for lipolysis, and 7.5% of future net sales for any licensed product sold for lipolysis and at least one other aesthetic procedure. As part of its agreement with Cynosure, CoolTouch has agreed to a Consent Judgment that it has infringed on the 873 patent and that the patent is valid and enforceable. CoolTouch also has granted to Cynosure and El.En. a royalty free license to any patents or patent applications owned or controlled by CoolTouch related to the treatment of fat and/or cellulite.

“This is an important victory for Cynosure,” said President and Chief Executive Officer Michael Davin. “In addition to the financial benefits of the agreement, the successful outcome validates the strength of our patent position in the emerging laser lipolysis industry. From our introduction of Smartlipo in 2006 to the subsequent enhancements we have made to the technology, we have established laser lipolysis as the gold standard for the minimally invasive removal of fat. Today, Smartlipo is the most recognized body contouring brand among U.S. consumers. The agreement with CoolTouch further enhances that brand and the technology behind our entire Smartlipo family of products.”

“Going forward, we plan to continue our strategy of enforcing our licensed intellectual property position around our laser lipolysis portfolio,” Davin concluded. “For the benefit of Cynosure and its shareholders, we intend to pursue licensing arrangements with additional laser lipolysis competitors that we believe have infringed upon the 873 patent.”

The 873 patent is a fundamental component of the Smartlipo LaserBodySculpting Workstation, a groundbreaking system designed as an alternative to traditional liposuction in patients with areas of localized fat. Cynosure received U.S. Food and Drug Administration clearance to market the Smartlipo workstation in late 2006. The product, which was launched in early 2007, uses a laser to deliver energy directly to subcutaneous fat cells, causing them to rupture. The emitted fat-melting energy also coagulates tissue, thus inducing collagen retraction and tissue tightening.

Under Cynosure’s license agreement with El.En., once Cynosure has recouped all of its legal costs incurred in the CoolTouch case, Cynosure will receive 60% of the future royalty payments from CoolTouch and El.En. will receive 40%.

About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure’s products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.

Cynosure
800.886.2966
www.cynosure.com

Source: Cynosure

Medical Aesthetics Book by RLI Consultant Patricia Owens Now Available

Milady’s Aesthetician Series, Lasers and Light Therapy, offers a unique approach into the science and technology of laser and light systems. The reader will be exposed to all aspects of this specialized field whether one is working in a medical spa, day spa, or medical clinic.

This book is designed to address areas of hair removal and facial / body rejuvenation from a beginning conceptual level into practical hands-on application. Detailed information of treatment protocols is explored starting with the initial consultation and skin care, to the selection of the appropriate cosmetic device, to the delivery of the laser/light technology.

ORDER NOW! – Click Here

Rockwell Laser Industries
800.94.LASER (945.2373)
www.rli.com

Source: RLI

Upcoming RLI Laser Safety Training Courses

Developed and taught by many of the leading experts in laser safety, RLI laser safety training courses have been recognized as the best in the industry.

RLI also offers Online Laser Safety Courses and On-site Laser Safety Courses that can be held at your facility.

Medical/Medical Aesthetics Courses

3/19/2010
Medical Laser Safety Officer- Cincinnati, OH

4/09/2010
Medical Aesthetics Seminar – Austin, TX

6/11/2010
Medical Laser Safety Officer – Chicago, IL

7/9/2010
Medical Laser Safety Officer – Las Vegas, NV

8/6/2010
Medical Aesthetics Seminar – San Antonio, TX

For more information, contact Leah Cridlin: training@rli.com.

About Rock Laser Industries
Rockwell Laser Industries (RLI) is recognized as the industry leader in providing services and products related to lasers and laser safety. Thirty years ago, R. James Rockwell, Jr. predicted tremendous growth in the use of lasers and therefore an increased need for laser safety training and consulting. Today, RLI provides comprehensive laser safety services and products to all sectors of the laser community.

RLI provides a wide selection of Safety Products, many of which can be customized. Products range from laser protective barriers and eye protection to instructional aids and the widely used LAZAN© hazard analysis software. The RLI Training Institute offers a variety of courses covering a wide spectrum of laser and laser safety topics. The instructors include top professionals from research, industrial, and medical fields.

RLI provides Specialized Consulting services on laser and laser safety topics. Services include safety audits, CDRH and IEC product certification and customized on-site training. RLI Communications also serves as a global laser safety information resource for the entire laser safety community. This mission is carried out through the RLI website, by presenting papers at industry conferences, authoring articles in trade journals, and participating on the ANSI, IEC, and other domestic and international laser safety standards committees. Rockwell Laser Industries combines unique activities to provide a full scope of safety related services to the laser industry.

RLI’s office in Cincinnati, Ohio serves as the main corporate headquarters for the company. It provides consulting services, training, and products related primarily to the laser and regulatory areas. Cincinnati is also the home base for the RLI consulting and on-site training services as well as technical product development. Rockwell Development Corporation serves as the center for development of laser audio-visual training programs, laser safety computer programs and other associated product development.

Rockwell Laser Industries
800.94.LASER (945.2373)
www.rli.com

Sourece: RLI

RLI Online Laser Safety Training Courses Now Available

RLI has introduced a new, updated series of SCORM compliant online Laser Safety training courses:

Laser Safety Awareness – Click Here
This three module introductory level course provides an overview of laser safety for personnel in and around the working environment with enclosed high powered laser systems as well as low powered visible lasers.

Introduction to Laser Safety for Healthcare Professionals – Click Here
This medical laser safety awareness course has been developed for those who are new to medical lasers. At the end of the course, you will understand basic laser science and be able to Identify the components of commonly used medical lasers and their delivery systems. You will also be able to identify the hazards associated with their use and what control measures are needed to ensure safe practices. Finally, you will understand how to apply national standards and guidelines to facility safety programs.

Rockwell Laser Industries
800.94.LASER (945.2737)
www.rli.com

Source: RLI

Texas Legislature Passes House Bill 449 Regulating Laser Hair Removal

The Texas Legislature recently passed legislation in House Bill 449 that establishes a regulatory program for laser hair removal. The Department of State Health Services will be charged with implementing that program.

The legislation requires every laser hair removal facility to be licensed by the department. It also requires that each individual who performs laser hair removal procedures, except physicians apply for a certificate in accordance with the provisions of the Texas Radiation Control Act, Health and Safety Code, Chapter 401.

By September 1, 2010, every Laser Hair Removal (LHR) facility must be licensed and each individual must apply for a LHR certificate.

Rockwell Laser Industries
800.94.LASER (945.2737)
www.rli.com

Source: RLI

Body Contouring Gets Refined with MedSculpt

A new technology called MedSculpt™ is about to give a boom to body contouring practices in the US. From Sound Surgical Technologies – the creators of the VASER® Lipo System – comes this non-invasive ultrasound and massage system designed to perfectly complement body contouring procedures. It’s the only system that has a specific lymphatic massage component with specialized elastomeric membranes and a patented massage sequence to enhance circulation.

MedSculpt is an innovative computerized system with specialized handpieces for elastomeric massage, ultrasound physiotherapy and zonal massage. By stimulating the subcutaneous tissues pre- and post-liposuction procedures, MedSculpt can:

* Loosen the fatty tissue matrix and relax the patient prior to infiltration
* Improve lymphatic and venous circulation
* Minimize postoperative pain and swelling
* Smooth out contour irregularities
* Temporarily improve the appearance of cellulite

“Liposuction with MedSculpt is a much more effective treatment. Performing liposuction alone sometimes results in bumps and uneven areas. MedSculpt definitely prevents these occurrences. The system restores a more natural appearance to the skin. The surface becomes more even and irregularities are smoothed out. Everything in our business is about results. With MedSculpt I am achieving better results, which has led to more satisfied patients,” says Dr. Stein Tveten, a plastic surgeon with clinics in Germany and Norway.

About Sound Surgical
Founded in 1998, Sound Surgical Technologies is a leading manufacturer and distributor of ultrasonic technologies and related techniques for aesthetic surgery, including the VASER® Lipo and MedSculpt™ Systems. An alternative to traditional tumescent liposuction, the VASER Lipo System uses an advanced ultrasonic fat removal technology that has become a trusted method in a society saturated with fad procedures. Demanded by physicians and patients alike, the results are smooth and consistent with fast patient recovery. MedSculpt is a non-invasive ultrasound and massage system used to increase lymphatic and venous circulation, minimize postoperative pain and swelling, and improve the appearance of cellulite. Both devices are FDA cleared for use in the US.

Sound Surgical
888.471.4777
www.vaser.com

Source: Sound Surgical